These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 14687596)
1. Oestrogen suppression--lessons from clinical studies. Lønning PE Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):33-45. PubMed ID: 14687596 [TBL] [Abstract][Full Text] [Related]
2. Biological rationale for endocrine therapy in breast cancer. Miller WR Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):1-32. PubMed ID: 14687595 [TBL] [Abstract][Full Text] [Related]
3. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms? Howell A; Howell SJ; Clarke R; Anderson E J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):227-37. PubMed ID: 11850229 [TBL] [Abstract][Full Text] [Related]
4. The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer. Howell SJ; Johnston SR; Howell A Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):47-66. PubMed ID: 14687597 [TBL] [Abstract][Full Text] [Related]
5. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer. Roseman BJ; Buzdar AU; Singletary SE J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969 [TBL] [Abstract][Full Text] [Related]
6. Aromatase inhibitors: current status. Ibrahim NK; Buzdar AU Am J Clin Oncol; 1995 Oct; 18(5):407-17. PubMed ID: 7572758 [TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer. Miller WR Semin Oncol; 2003 Aug; 30(4 Suppl 14):3-11. PubMed ID: 14513432 [TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitors in early breast cancer treatment. Mauriac L; Smith I Semin Oncol; 2003 Aug; 30(4 Suppl 14):46-57. PubMed ID: 14513436 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in endocrine therapy of breast cancer. Howell A; Dowsett M BMJ; 1997 Oct; 315(7112):863-6. PubMed ID: 9353509 [No Abstract] [Full Text] [Related]
10. Endocrine treatment of advanced breast cancer. Dowsett M Acta Oncol; 1996; 35 Suppl 5():68-72. PubMed ID: 9142970 [TBL] [Abstract][Full Text] [Related]
11. Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer. Ingle JN; Suman VJ; Jordan VC; Dowsett M Endocr Relat Cancer; 1999 Jun; 6(2):265-9. PubMed ID: 10731119 [TBL] [Abstract][Full Text] [Related]
12. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer. Miller WR; Stuart M; Sahmoud T; Dixon JM Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282 [TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of aromatase inhibitors. Miller WR; Jackson J Expert Opin Investig Drugs; 2003 Mar; 12(3):337-51. PubMed ID: 12605559 [TBL] [Abstract][Full Text] [Related]
14. Use of aromatase inhibitors in breast carcinoma. Santen RJ; Harvey HA Endocr Relat Cancer; 1999 Mar; 6(1):75-92. PubMed ID: 10732791 [TBL] [Abstract][Full Text] [Related]
15. Third generation aromatase inhibitors in metastatic breast cancer patients failing tamoxifen. Randomized comparisons with megestrol acetate: a critical review. Bonte J Eur J Gynaecol Oncol; 2000; 21(6):555-9. PubMed ID: 11214609 [No Abstract] [Full Text] [Related]
16. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Gibson LJ; Dawson C; Lawrence DH; Bliss JM Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effects of letrozole. Miller WR; Anderson TJ; Dixon JM Cancer Invest; 2002; 20 Suppl 2():15-21. PubMed ID: 12442345 [TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibitors in breast cancer: current and evolving roles. Hill J; Moore H Cleve Clin J Med; 2002 Jul; 69(7):561-7. PubMed ID: 12109640 [TBL] [Abstract][Full Text] [Related]